Received Nov 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 946915 | IM / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | E9X9A | IM / LA |
PATIENT REPORTED THAT SUBSEQUENT TO RECEIVING THE TWO VACCINES ( AT AROUND 10:15 AM) DESCRIBED ABOVE SHE STARTED FEELING A FEW SYMPTOMS SHE HADN'T EXPERIENCED WITH ANY OTHER VACCINE IN THE PAST. FIRST SYMPTOM PRESENTED WAS NAUSEA, FOLLOWED BY INCREASE IN HEART RATE AND THEN A SENSATION OF ITCH ALL THROUGHOUT THE BODY. SOME HIVES AND REDNESS WERE OBSERVED IN HER LEGS AND ARMS. AT AROUND 11:00 SHE RETURNED TO THE PHARMACY TO NOTIFY ABOUT THESE SYMPTOMS. IMMEDIATELY UPON HER DESCRIPTION AND INITIAL ASSESSMENT, IT WAS DETERMINED SHE MIGHT'VE BEEN EXPERIENCING AN ANAPHYLACTIC REACTION. 911 WAS CALLED AND EMERGENCY RESPONSE STAFF ARRIVED WITHIN 5 MINUTES AND DECIDED TO TAKE PATIENT TO THE LOCAL EMERGENCY CENTER FOR FURTHER CARE AND TRIAGE.
N/A
ARTHRITIS, GASTRITIS, HYPERTENSION
UNKNOWN
NKDA